Prolonged pain to hospital time is associated with increased plasma advanced oxidation protein products and poor prognosis in patients with percutaneous coronary intervention for ST-elevation myocardial infarction

Heart and Vessels

Volumn 25, Issue 5, 2010, Pages 374-378

  Feng, Yi ^a   Shen, Chengxing ^a   Ma, Genshan ^a   Wang, Jihui ^a   Chen, Zhong ^a   Dai, Qiming ^a   Zhi, Hong ^a   Yang, Chengjian ^a   Fu, Qiang ^a   Shang, Gensheng ^a   Guan, Yuanyuan ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Advanced oxidation protein products; Coronary artery disease; Oxidative stress; Percutaneous coronary intervention

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HEART DISEASE; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATIENT CODING; PERCUTANEOUS CORONARY INTERVENTION; PRECORDIAL PAIN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TIME;

ADULT; AGED; ANGINA PECTORIS; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHINA; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; PATIENT READMISSION; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TRANSPORTATION OF PATIENTS; TREATMENT OUTCOME; UP-REGULATION;

EID: 77956032255     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-009-1220-8     Document Type: Article

References (14)

1. H. Cai D.G. Harrison 2000 Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress Circ Res 87 10 840 844 1:CAS:528: DC%2BD3cXoslygsrk%3D 11073878
2. C.X. Shen H.Z. Chen J.B. Ge 2004 The role of inflammatory stress in acute coronary syndrome Chin Med J (Engl) 117 133 139
3. V. Witko-Sarsat M. Friedlander C. Capeillère-Blandin T. Nguyen-Khoa A.T. Nguyen J. Zingraff P. Jungers B. Descamps-Latscha 1996 Advanced oxidation protein products as a novel marker of oxidative stress in uremia Kidney Int 49 1304 1313 10.1038/ki.1996.186 1:CAS:528:DyaK28Xkslagsbs%3D 8731095
4. D. Tovbin D. Mazor M. Vorobiov C. Chaimovitz N. Meyerstein 2002 Induction of protein oxidation by intravenous iron in hemodialysis patients: role of inflammation Am J Kidney Dis 40 1005 1012 10.1053/ajkd.2002.36334 1:CAS:528:DC%2BD38XptVKgur0%3D 12407646
5. B. Descamps-Latscha V. Witko-Sarsat T. Nguyen-Khoa A.T. Nguyen V. Gausson N. Mothu G.M. London P. Jungers 2005 Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients Am J Kidney Dis 45 39 47 10.1053/j.ajkd.2004.09.011 1:CAS:528:DC%2BD2MXhtVOrtr4%3D 15696442
6. T. Drüeke V. Witko-Sarsat Z. Massy B. Descamps-Latscha A.P. Guerin S.J. Marchais V. Gausson M. Gérard G.M. London 2002 Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease Circulation 106 2212 2217 10.1161/01.CIR.0000035250. 66458.67 12390950
7. H. Kaneda J. Taguchi K. Ogasawara 2002 Increased level of advanced oxidation protein products in patients with coronary artery disease Atherosclerosis 162 221 225 10.1016/S0021-9150(01)00706-7 1:CAS:528: DC%2BD38Xis1eit7c%3D 11947918
8. M. Skvarilova A. Bulava D. Stejskal S. Adamovská J. Bartek 2005 Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 149 83 87 1:CAS:528:DC%2BD2MXhtFOjsrbM 16170393
9. H. Oka S. Ikeda S. Koga Y. Miyahara S. Kohno 2008 Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases Heart Vessels 23 249 256 10.1007/s00380-008-1038-9 18649055
10. N. Kubota T. Kasai K. Miyauchi W. Njaman K. Kajimoto Y. Akimoto K. Takahiko K. Yokoyama T. Kurata H. Daida 2008 Therapy with statins and aspirin enhances long-term outcome of percutaneous coronary intervention Heart Vessels 23 35 39 10.1007/s00380-007-1007-8 18273544
11. H. Tsutsui 2001 Oxidative stress in heart failure: the role of mitochondria Intern Med 40 1177 1182 10.2169/internalmedicine.40.1177 1:CAS:528:DC%2BD38XisVemtb0%3D 11813840
12. M. Crisby K. Kublickiene L. Henareh S. Agewall 2009 Circulating levels of autoantibodies to oxidized low-density lipoprotein and C-reactive protein levels correlate with endothelial function in resistance arteries in men with coronary heart disease Heart Vessels 24 90 95 10.1007/s00380-008-1089-y 19337791
13. R. Ferrari P. Pepi F. Ferrari F. Nesta M. Benigno O. Visioli 2001 Metabolic derangement in ischemic heart disease and its therapeutic control Am J Cardiol 82 5A 2K 13K
14. S. Gambert C. Vergely R. Filomenko D. Moreau A. Bettaieb L.H. Opie L. Rochette 2006 Adverse effects of free fatty acid associated with increased oxidative stress in postischemic isolated rat hearts Mol Cell Biochem 283 1-2 147 152 10.1007/s11010-006-2518-9 1:CAS:528:DC%2BD28XovVeqtg%3D%3D 16444597